LY2228820
-
Catalog numberB1702-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameLY2228820; LY 2228820; LY-2228820; LY2228820 dimesylate; Ralimetinib dimesylate; 5-(2-(tert-butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate; 5-[2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)imidazo[4,5-b]pyridin-2-amine;methanesulfonic acid
-
DescriptionLY2228820 is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, but does not alter p38 MAPK activation.
-
CAS Number862507-23-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₆H₃₇FN₆O₆S₂
-
Molecular Weight612.74
-
Cell PermeableYes
-
Purity>98%
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA novel and potent inhibitor of p38 MAPK
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD28101032
-
PubChem CID11570805
-
SMILESCC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N.CS(=O)(=O)O.CS(=O)(=O)O
-
InChiInChI=1S/C24H29FN6.2CH4O3S/c1-23(2,3)13-31-20-17(28-22(31)26)12-11-16(27-20)19-18(14-7-9-15(25)10-8-14)29-21(30-19)24(4,5)6;2*1-5(2,3)4/h7-12H,13H2,1-6H3,(H2,26,28)(H,29,30);2*1H3,(H,2,3,4)
-
InChi KeyNARMJPIBAXVUIE-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameLY2228820
-
Alternative nameLY2228820
-